Skip to content

Cohort Study on Multi-omics Integrative Analysis to Decipher the Mechanism of Malignant Transformation in Pulmonary Ground-Glass Nodules

Cohort Study on Multi-omics Integrative Analysis to Decipher the Mechanism of Malignant Transformation in Pulmonary Ground-Glass Nodules

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500114804
Enrollment
Unknown
Registered
2025-12-17
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary nodule

Interventions

Observation group:None

Sponsors

The Second Affiliated Hospital of Army Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Retrospective Cohort Inclusion Criteria: 1.Patients clinically diagnosed with pulmonary ground-glass nodules and clearly indicated for radical surgery; 2. Patients who have not received any anticancer treatment; 3. Patients with detailed and complete clinical medical records; 4. Patients aged between 18 and 70 years. Prospective Cohort Inclusion Criteria: 1.Patients clinically diagnosed with pulmonary ground-glass nodules and clearly indicated for radical surgery; 2. Patients who have not received any anticancer treatment; 3. Patients with detailed and complete clinical medical records; 4. Patients aged between 18 and 70 years; 5. Patients who have obtained informed consent authorization.

Exclusion criteria

Exclusion criteria: Retrospective Cohort Exclusion Criteria: 1.Patients with a history of other malignant tumors; 2.Patients with major metabolic disorders or systemic diseases; 3.Pregnant or lactating women; 4.Severe infection or inflammatory reaction within the past three months; 5.History of long-term medication that may affect study outcomes; 6.Patients with significant hepatic or renal insufficiency. Prospective Cohort Exclusion Criteria: 1.Patients with a history of other malignant tumors; 2.Patients with major metabolic disorders or systemic diseases; 3.Pregnant or lactating women; 4.Severe infection or inflammatory reaction within the past three months; 5.History of long-term medication that may affect study outcomes; 6.Patients with significant hepatic or renal insufficiency.

Design outcomes

Primary

MeasureTime frame
Pathological diagnosis;

Countries

China

Contacts

Public ContactQuanxing Liu

The Second Affiliated Hospital, Army Medical

quanxing9999@qq.com+86 156 8366 8297

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026